Patent · US Expired

17.beta.-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives

US6197761A · kind A · utility

29Cited by
2References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 24, 1998
Grant dateMar 6, 2001
Priority date
Expiry dateJun 24, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J31/006
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of the androstane series are described having general formula ##STR1## and solvates thereof, in which R.sub.1 represents O, S or NH; R.sub.2 individually represents OC(.dbd.O)C.sub.1-6 alkyl; R.sub.3 individually represents hydrogen, methyl (which may be in either the .alpha. or .beta. configuration) or methylene; or R.sub.2 and R.sub.3 together represent ##STR2## where R.sub.6 and R.sub.7 are the same or different and each represents hydrogen or C.sub.1-6 alkyl; R.sub.4 and R.sub.5 are the same or different and each represents hydrogen or halogen and {character pullout} represents a single or a double bond. These compounds and their solvates have use in medicine as anti-inflammatory or anti-allergic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.